Psyence Biomedical (PBM) Shares Outstanding (2023 - 2026)

Psyence Biomedical (PBM) posted Shares Outstanding (Entity) of $552282.0 for Q1 2026, up 77.98% on a QoQ basis from $310310.0 in Q3 2023.

Analysis

Psyence Biomedical (PBM) Shares Outstanding (2023 - 2026) Analysis & Trends

Psyence Biomedical has reported Shares Outstanding (Entity) for 2 years, with the latest figure at $552282.0 in Q1 2026.

On a quarterly basis, Shares Outstanding (Entity) changed N/A year-over-year to $552282.0 in Q1 2026; TTM through Mar 2026 was $552282.0, a N/A change from a year earlier, with the FY2026 full-year figure at $552282.0, changed N/A from the prior year.
Shares Outstanding (Entity) was $552282.0 for Q1 2026 at Psyence Biomedical, up from $310310.0 in the prior quarter.
The five-year high for Shares Outstanding (Entity) was $552282.0 in Q1 2026, with the low at $310310.0 in Q3 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Qtr)
1	Amgen	209.88 Bn	195.89 Bn	7.24 Bn	540.00 Mn
2	Gilead Sciences	179.94 Bn	176.76 Bn	6.22 Bn	1.24 Bn
3	Vertex Pharmaceuticals	131.92 Bn	124.07 Bn	2.84 Bn	253.70 Mn
4	Regeneron Pharmaceuticals	81.96 Bn	73.96 Bn	3.93 Bn	102.80 Mn
5	Argenx Se	61.21 Bn	56.02 Bn	1.37 Bn	61.30 Mn
6	Moderna	53.53 Bn	48.39 Bn	52.00 Mn	398.00 Mn
7	Alnylam Pharmaceuticals	33.65 Bn	30.34 Bn	992.69 Mn	133.61 Mn
8	Biogen	31.83 Bn	30.55 Bn	1.96 Bn	147.70 Mn
9	Roivant Sciences	29.64 Bn	29.64 Bn	1.16 Mn	720.78 Mn
10	Psyence Biomedical	2.69 Mn	2.69 Mn	-	552,282.00

Historic Data

Download Data